UWO Now: GLP-1 Medications Explained
In this episode of UWO Now, host Wendell Ray speaks with Jessica Habeck, DNP, from the UW-Oshkosh School of Nursing about GLP‑1 medications and their role in weight loss, diabetes treatment, and metabolic health.
The discussion explains how drugs like Ozempic, Wegovy, Mounjaro, and Zepbound mimic natural hormones that regulate appetite and blood sugar. The conversation also addresses who qualifies for these medications, the dangers of compound and counterfeit versions, and why GLP‑1 therapies must be combined with lifestyle and medical supervision. A clear and practical conversation for anyone curious about the science and safety behind the most talked‑aboutweight‑loss medications today.
00:00 Cold Open — GLP‑1 Medications Beyond the Headlines00:36 What Are GLP‑1 Medications?01:19 How GLP‑1 Hormones Work in the Body02:13 Two Types of GLP‑1 Medications02:52 The History of GLP‑1 Drugs04:17 Who Should Take GLP‑1 Medications?05:09 They Aren’t for Everyone Who Wants to Lose Weight
07:24 How Doctors Evaluate Patients for GLP‑1 Treatment08:35 These Medications Are Long‑Term Therapies 13:27 Why GLP‑1 Treatment Requires a Team Approach15:24 Who Should NOT Take GLP‑1 Drugs18:52 The Risks of Online and Counterfeit Weight Loss Drugs24:21 Long‑Term Safety of GLP‑1 Medications 25:48 New FDA Approval for Sleep Apnea Treatment 29:56 ClosingGLP‑1 medications, GLP‑1 weight loss drugs, Ozempic explained, Wegovy weight loss, Mounjaro medication,Zepbound sleep apnea, GLP‑1 hormone function, obesity treatment medications, diabetes medications GLP‑1, semaglutide weight loss, tirzepatide medication, GLP‑1side effects, GLP‑1 safety, compounded GLP‑1 drugs, counterfeit weight loss drugs, obesity medicine, metabolic health, UWO Now podcast, Jessica HabeckGLP‑1 receptor agonists, incretin hormones, semaglutide medications, tirzepatide medications, appetite regulation hormones, insulin regulation, metabolic health treatments, obesity medicine therapies, diabetes management drugs, weight loss pharmacology, endocrine metabolismregulation, FDA approved GLP‑1 drugs, sleep apnea and obesity, medical weight loss treatments, healthcareprovider supervised weight loss